Literature DB >> 33674410

Unique Human and Mouse β-Cell Senescence-Associated Secretory Phenotype (SASP) Reveal Conserved Signaling Pathways and Heterogeneous Factors.

Ayush Midha1, Hui Pan2, Cristian Abarca1, Joshua Andle1, Priscila Carapeto1, Susan Bonner-Weir1, Cristina Aguayo-Mazzucato3.   

Abstract

The aging of pancreatic β-cells may undermine their ability to compensate for insulin resistance, leading to the development of type 2 diabetes (T2D). Aging β-cells acquire markers of cellular senescence and develop a senescence-associated secretory phenotype (SASP) that can lead to senescence and dysfunction of neighboring cells through paracrine actions, contributing to β-cell failure. In this study, we defined the β-cell SASP signature based on unbiased proteomic analysis of conditioned media of cells obtained from mouse and human senescent β-cells and a chemically induced mouse model of DNA damage capable of inducing SASP. These experiments revealed that the β-cell SASP is enriched for factors associated with inflammation, cellular stress response, and extracellular matrix remodeling across species. Multiple SASP factors were transcriptionally upregulated in models of β-cell senescence, aging, insulin resistance, and T2D. Single-cell transcriptomic analysis of islets from an in vivo mouse model of reversible insulin resistance indicated unique and partly reversible changes in β-cell subpopulations associated with senescence. Collectively, these results demonstrate the unique secretory profile of senescent β-cells and its potential implication in health and disease.
© 2021 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33674410      PMCID: PMC8173799          DOI: 10.2337/db20-0553

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  59 in total

1.  Identification of cell types from single-cell transcriptomes using a novel clustering method.

Authors:  Chen Xu; Zhengchang Su
Journal:  Bioinformatics       Date:  2015-02-11       Impact factor: 6.937

2.  limma powers differential expression analyses for RNA-sequencing and microarray studies.

Authors:  Matthew E Ritchie; Belinda Phipson; Di Wu; Yifang Hu; Charity W Law; Wei Shi; Gordon K Smyth
Journal:  Nucleic Acids Res       Date:  2015-01-20       Impact factor: 16.971

3.  Single-Cell Transcriptomics of the Human Endocrine Pancreas.

Authors:  Yue J Wang; Jonathan Schug; Kyoung-Jae Won; Chengyang Liu; Ali Naji; Dana Avrahami; Maria L Golson; Klaus H Kaestner
Journal:  Diabetes       Date:  2016-06-30       Impact factor: 9.461

4.  Interleukin-1-receptor antagonist in type 2 diabetes mellitus.

Authors:  Claus M Larsen; Mirjam Faulenbach; Allan Vaag; Aage Vølund; Jan A Ehses; Burkhardt Seifert; Thomas Mandrup-Poulsen; Marc Y Donath
Journal:  N Engl J Med       Date:  2007-04-12       Impact factor: 91.245

5.  High passage MIN6 cells have impaired insulin secretion with impaired glucose and lipid oxidation.

Authors:  Kim Cheng; Viviane Delghingaro-Augusto; Christopher J Nolan; Nigel Turner; Nicole Hallahan; Sofianos Andrikopoulos; Jenny E Gunton
Journal:  PLoS One       Date:  2012-07-13       Impact factor: 3.240

Review 6.  Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity.

Authors:  Allyson K Palmer; Tamara Tchkonia; Nathan K LeBrasseur; Eduardo N Chini; Ming Xu; James L Kirkland
Journal:  Diabetes       Date:  2015-07       Impact factor: 9.461

7.  Massively parallel digital transcriptional profiling of single cells.

Authors:  Grace X Y Zheng; Jessica M Terry; Phillip Belgrader; Paul Ryvkin; Zachary W Bent; Ryan Wilson; Solongo B Ziraldo; Tobias D Wheeler; Geoff P McDermott; Junjie Zhu; Mark T Gregory; Joe Shuga; Luz Montesclaros; Jason G Underwood; Donald A Masquelier; Stefanie Y Nishimura; Michael Schnall-Levin; Paul W Wyatt; Christopher M Hindson; Rajiv Bharadwaj; Alexander Wong; Kevin D Ness; Lan W Beppu; H Joachim Deeg; Christopher McFarland; Keith R Loeb; William J Valente; Nolan G Ericson; Emily A Stevens; Jerald P Radich; Tarjei S Mikkelsen; Benjamin J Hindson; Jason H Bielas
Journal:  Nat Commun       Date:  2017-01-16       Impact factor: 14.919

8.  KPNB1-mediated nuclear import is required for motility and inflammatory transcription factor activity in cervical cancer cells.

Authors:  Tamara Stelma; Virna D Leaner
Journal:  Oncotarget       Date:  2017-05-16

9.  Identification of HSP90 inhibitors as a novel class of senolytics.

Authors:  Heike Fuhrmann-Stroissnigg; Yuan Yuan Ling; Jing Zhao; Sara J McGowan; Yi Zhu; Robert W Brooks; Diego Grassi; Siobhan Q Gregg; Jennifer L Stripay; Akaitz Dorronsoro; Lana Corbo; Priscilla Tang; Christina Bukata; Nadja Ring; Mauro Giacca; Xuesen Li; Tamara Tchkonia; James L Kirkland; Laura J Niedernhofer; Paul D Robbins
Journal:  Nat Commun       Date:  2017-09-04       Impact factor: 14.919

10.  Single-cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes.

Authors:  Nathan Lawlor; Joshy George; Mohan Bolisetty; Romy Kursawe; Lili Sun; V Sivakamasundari; Ina Kycia; Paul Robson; Michael L Stitzel
Journal:  Genome Res       Date:  2016-11-18       Impact factor: 9.043

View more
  4 in total

Review 1.  Targeting pancreatic β cells for diabetes treatment.

Authors:  Chirag Jain; Sara Bilekova; Heiko Lickert
Journal:  Nat Metab       Date:  2022-09-21

2.  DNA damage to β cells in culture recapitulates features of senescent β cells that accumulate in type 1 diabetes.

Authors:  Gabriel Brawerman; Jasmine Pipella; Peter J Thompson
Journal:  Mol Metab       Date:  2022-06-02       Impact factor: 8.568

3.  Characterization of the Secretome, Transcriptome, and Proteome of Human β Cell Line EndoC-βH1.

Authors:  Maria Ryaboshapkina; Kevin Saitoski; Ghaith M Hamza; Andrew F Jarnuczak; Séverine Pechberty; Claire Berthault; Kaushik Sengupta; Christina Rye Underwood; Shalini Andersson; Raphael Scharfmann
Journal:  Mol Cell Proteomics       Date:  2022-04-02       Impact factor: 7.381

Review 4.  Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells.

Authors:  Takaaki Murakami; Nobuya Inagaki; Hiroshi Kondoh
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-31       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.